Abivax S.A. (ABVX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Abivax S.A.

    NASDAQ: ABVX · Real-Time Price · USD
    83.92
    1.05 (1.27%)
    At close: Oct 03, 2025, 3:59 PM
    93.99
    12.00%
    Pre-market: Oct 06, 2025, 07:59 AM EDT

    Abivax S.A. Cash Flow Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -176.24M -147.74M -60.74M -42.56M
    Depreciation & Amortization
    		 1.1M 707K 485K 156K
    Stock-Based Compensation
    		 20.22M 8.18M -1.16M 828K
    Other Working Capital
    		 276K 3.74M 74K n/a
    Other Non-Cash Items
    		 -577K 9.65M 9.48M -1.84M
    Deferred Income Tax
    		 n/a 7.93M n/a -828K
    Change in Working Capital
    		 1.42M 21.27M -2M -668K
    Operating Cash Flow
    		 -154.07M -100.01M -53.94M -45.66M
    Capital Expenditures
    		 -643K -265K -323K -1.64M
    Cash Acquisitions
    		 n/a n/a -2.91M 312K
    Purchase of Investments
    		 n/a -9.35M -470K -126K
    Sales Maturities Of Investments
    		 n/a 741K 218K -312K
    Other Investing Acitivies
    		 16.4M -1.62M -8.57M 312K
    Investing Cash Flow
    		 15.76M -10.49M -12.03M -1.46M
    Debt Repayment
    		 37.49M 15.24M -9.71M 19.13M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -9.71M -28.06M -4.45M -10.3M
    Financial Cash Flow
    		 28.21M 340.57M 32.21M 78.51M
    Net Cash Flow
    		 -107.72M 224.99M -33.75M 31.4M
    Free Cash Flow
    		 -154.72M -100.28M -54.26M -47.3M

    Add to Watchlist